British Pharmacopoeia – Consultation for Vector Copy Number guidance revision and addition of Polymerase Chain Reaction validation annexes (from Catapult’s regulatory round-up for December 2024)
The BP has prepared an update to the guidance for Vector Copy Number, which includes a revision to the guidance itself as well as new Polymerase Chain Reaction validation plans. This update is intended to...